RE-COVER II: Dabigatran Met 6-Month Primary Endpoint for Treatment of DVT, PE

Published January 3, 2014

RE-COVER II: Dabigatran met 6-month primary endpoint for treatment of DVT, PE
Schulman, of McMaster University and Henderson Research Center, Hamilton, Ontario, Canada, and colleagues found similar rates of death, adverse events and ACS between the groups. When the researchers pooled data from RE-COVER and RE-COVER …
Read more on Healio

The Canadian Press looks back at what made news in 2013
17: After years of insisting he was innocent, disgraced cyclist Lance Armstrong admitted in a televised interview with Oprah Winfrey that he took performance-enhancing drugs in each of his seven Tour de France wins. 18: The Supreme Court …. 4: A …
Read more on Macleans.ca

From scandal-plagued politicians to natural disasters, a look back at 2013
17 – After years of insisting he was innocent, disgraced cyclist Lance Armstrong admitted in a televised interview with Oprah Winfrey that he took performance-enhancing drugs in each of his seven Tour de France wins. 18 – The Supreme Court of …. 4 …
Read more on Calgary Herald